Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Fruchart

Showing results (391-400 of 562) with videos related to

Pageof 57
Sort By:
Biochimica Et Biophysica Acta|March 14, 1989
Determination of the LDL receptor binding capacity of human lymphocytes by immunocytofluorimetric assayS Benhamamouch, J P Kuznierz, G Agnani, et al.
Science (New York, N.Y.)|August 16, 1996
Protection against atherogenesis in mice mediated by human apolipoprotein A-IVN Duverger, G Tremp, J M Caillaud, et al.
The Journal of Biological Chemistry|June 2, 1995
Modulation of cholesterol efflux from Fu5AH hepatoma cells by the apolipoprotein content of high density lipoprotein particles. Particles containing various proportions of apolipoproteins A-I and A-IIL Lagrost, C Dengremont, A Athias, et al.
Atherosclerosis|June 1, 1997
Distribution of apolipoprotein E between apo B- and non apo B-containing lipoproteins according to apo E phenotypeG Luc, P Ducimetiere, J M Bard, et al.
Annales De Biologie Clinique|January 1, 1989
[Quantitative analysis of apolipoproteins and lipoprotein particles in patients with head injuries]O Kabbaj, R Saile, N Ghalim, et al.
Journal of Immunological Methods|April 22, 1988
Antibodies of predetermined specificity to apolipoprotein C-II elicited with a synthetic peptide. Characterization and use for immunoassaysC Delpierre, C Fievet, V Equagoo, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1987
Chemical approach to synthetic immunogens in clinical chemistryC Delpierre, C Martin, J C Gesquiere, et al.
Circulation Research|September 4, 1999
Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathwayP Delerive, F Martin-Nizard, G Chinetti, et al.
Revue D'Epidemiologie Et De Sante Publique|April 10, 2003
[Biological banks of the prospective cohort PRIME Study]G Luc, J Ferri res, A Evans, et al.
Biochimica Et Biophysica Acta|July 29, 1992
Isolation and characterization of two sub-species of Lp(a), one containing apo E and one free of apo EJ M Bard, S Delattre-Lestavel, V Clavey, et al.
Pageof 57

Showing results (391-400 of 562) with videos related to

Sort By:
Pageof 57
Biochimica Et Biophysica Acta|March 14, 1989
Determination of the LDL receptor binding capacity of human lymphocytes by immunocytofluorimetric assayS Benhamamouch, J P Kuznierz, G Agnani, et al.
Science (New York, N.Y.)|August 16, 1996
Protection against atherogenesis in mice mediated by human apolipoprotein A-IVN Duverger, G Tremp, J M Caillaud, et al.
The Journal of Biological Chemistry|June 2, 1995
Modulation of cholesterol efflux from Fu5AH hepatoma cells by the apolipoprotein content of high density lipoprotein particles. Particles containing various proportions of apolipoproteins A-I and A-IIL Lagrost, C Dengremont, A Athias, et al.
Atherosclerosis|June 1, 1997
Distribution of apolipoprotein E between apo B- and non apo B-containing lipoproteins according to apo E phenotypeG Luc, P Ducimetiere, J M Bard, et al.
Annales De Biologie Clinique|January 1, 1989
[Quantitative analysis of apolipoproteins and lipoprotein particles in patients with head injuries]O Kabbaj, R Saile, N Ghalim, et al.
Journal of Immunological Methods|April 22, 1988
Antibodies of predetermined specificity to apolipoprotein C-II elicited with a synthetic peptide. Characterization and use for immunoassaysC Delpierre, C Fievet, V Equagoo, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1987
Chemical approach to synthetic immunogens in clinical chemistryC Delpierre, C Martin, J C Gesquiere, et al.
Circulation Research|September 4, 1999
Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathwayP Delerive, F Martin-Nizard, G Chinetti, et al.
Revue D'Epidemiologie Et De Sante Publique|April 10, 2003
[Biological banks of the prospective cohort PRIME Study]G Luc, J Ferri res, A Evans, et al.
Biochimica Et Biophysica Acta|July 29, 1992
Isolation and characterization of two sub-species of Lp(a), one containing apo E and one free of apo EJ M Bard, S Delattre-Lestavel, V Clavey, et al.
Pageof 57